Tri-Vision Technologies Signs First Commercialization Agreement; UK's Largest Healthcare Retailer to Distribute Pheromone's Fertility Monitor.Business Editors/Health & Medical Writers TORONTO--(BUSINESS WIRE)--June 18, 2002 Tri-Vision International Ltd./Ltee (TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension :TVL TVL Travel TVL TV Lines (resolution) TVL Transvaal TVL The Vampire Lestat (Anne Rice) TVL TV Land (television station) TVL Tenth-Value Layer ) and Pheromone pheromone Any chemical compound secreted by an organism in minute amounts to elicit a particular reaction from other organisms of the same species. Pheromones are widespread among insects and vertebrates (except birds) and are present in some fungi, slime molds, and algae. Sciences Corp. (TSX Venture Exchange TSX Venture Exchange Originally called the Canadian Venture Exchange (CDNX), this was a result of the merger of the Vancouver and Alberta stock exchanges. The goal of TSX Venture Exchange is to provide venture companies with effective access to capital while protecting investors. :PHS (Personal Handyphone System) A TDMA-based cellular phone system introduced in Japan in mid-1995. Operating in the 1880-1930 MHz band, PHS uses microcells that cover an area only 100 to 500 meters in diameter, resulting in lower equipment costs but requiring more base ), a Toronto-based biotech R & D company with proprietary technology in the field of non-invasive fertility and ovulation ovulation /ovu·la·tion/ (ov?u-la´shun) the discharge of a secondary oocyte from a graafian follicle.ov´ulatory o·vu·la·tion n. The discharge of an ovum from the ovary. detection are pleased to announce the signing of a Letter of Intent (LOI LOI Letter of Indemnity (international trade and carriage business) LOI Letter Of Intent LOI Loss On Ignition LOI Letter of Inquiry LOI Lack Of Information LOI Lack of Interest LOI Letter of Invitation LOI List Of Items ) for the distribution of Pheromone's PSC (Public Service Commission) Same as PUC. Fertility Monitor(TM) in the United Kingdom. The LOI is expected to be followed by a definitive Distribution Agreement. The distribution agreement is to provide for the sale of the PSC Fertility Monitor exclusively in Boots Company PLC stores across the United Kingdom over a three-year period. Boots is the UK's largest retailer of health products in the United Kingdom with over 1,400 retail outlets and a strong Internet-based pharmacy network. Under the proposed distribution agreement Boots would be committed to selling a significant number of units of the product during each year to maintain exclusivity. The product is expected to be available in Boots outlets before year-end. The PSC Fertility Monitor is a fertility cycle monitoring device for the consumer and professional medical market. The PSC Fertility Monitor looks to set a new benchmark in providing a reliable "predictive" approach to natural, cycle-based family planning. The PSC Fertility Monitor is a non-invasive method of predicting the fertility window and ovulation date through the measurements of perspiration ion changes on the surface of the skin through a unique combination of bio-sensing and computer technologies. These changes in female perspiration allow for the prediction of ovulation up to 4 days before the ovulation day. Pheromone advises that in their recent US trial, the PSC Fertility Monitor detected more days of the conception window (the days when sexual intercourse can lead to a pregnancy) than the LH test strip product or the basal body temperature method Noun 1. basal body temperature method - natural family planning in which the fertile period of the woman's menstrual cycle is inferred by noting the rise in basal body temperature that typically occurs with ovulation . This determination, coupled with the published literature on the chances of conception during this window strongly suggests that women who use the PSC Fertility Monitor as a means of identifying their fertile window to time intercourse, can expect a substantially higher probability of conception or a substantially shorter time to pregnancy than if they relied solely on home-based LH test kits as a means to time intercourse. This business agreement is the first for Tri-Vision's newly-established subsidiary, Tri-Vision Technologies International Inc., which was created for the development and marketing of innovative technologies. "While this is our first endeavor in delivering new technologies for other companies, our core business has been operating internationally for years and we continue to show success with our V-chip licensing to internationally-based television manufacturers. This relationship with Pheromone and Boots is a clear demonstration of Tri-Vision Technologies' ability to market internationally" stated Tri-Vision Technologies President Toshinori Ikebe. "The signing of this LOI represents a significant step in the execution of our commercialization strategy" stated Christopher Neuman President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Pheromone. "Much effort has been put into the development of our Fertility Monitor technology and this solid expression of interest from one of the world's leading health care retailing organizations is a validation of our efforts to bring this technology to couples around the world." Tri-Vision International Ltd./Ltee is a public company founded in 1986. The Company trades on Canada's Toronto Stock Exchange Toronto Stock Exchange (TSE) Canada's largest stock exchange, trading approximately 1,200 company stocks and 33 options. under the symbol TVL. The public company has two wholly owned subsidiaries: Tri-Vision Electronics Inc. and Tri-Vision Technologies International Inc. For investor or media information, contact John Carswell, Century Communications Corporation toll free at 1-888-298-8551. For further information, visit the Company's website at www.tri-vision.ca. The Toronto Stock Exchange has not reviewed and does not approve or disapprove of the adequacy or accuracy of this release. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion